Skip to content

Investigating the effect of follow-up care program in migraine patients

Evaluation of the effect of follow-up care program using a smart phone application compared to standard care on migraine treatment management of patients with migraine headache

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241102063570N1
Enrollment
120
Registered
2024-12-06
Start date
2024-12-23
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Providing educational information to patients about migraine disease in order to prevent or reduce the number of migraine headache attacks and its accompanying complications.. Migraine

Interventions

Intervention 1: Intervention group: 60 patients with migraine headaches, who are taught for 12 weeks with educational software about migraine disease and diet and migraine medications, ways to prevent

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Suffering from migraine headache Age range from 20 to 60 years old Having the ability to read and write Having an Android mobile phone . Ability to work with software Informed consent

Exclusion criteria

Exclusion criteria: Migraine patient whose number of attacks is less than twice a month Get a score higher than 20 for the level of depression and a score higher than 14 for the level of anxiety and a score higher than 25 for the level of stress according to the DASS-21 Botox therapeutic injection

Design outcomes

Primary

MeasureTime frame
Severity of migraine headache pain. Timepoint: Migraine headache pain intensity is measured at the beginning of the study and before the start of the intervention in both control and intervention groups, and 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 days after The intervention is measured in the intervention group. Method of measurement: Pain scoring tool.;Migraine headache duration. Timepoint: Migraine headache pain intensity is measured at the beginning of the study and before the start of the intervention in both control and intervention groups, and 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 days after the intervention is measured in the intervention group. Method of measurement: Patient report.;Number of migraine attacks. Timepoint: The number of migraine headache attacks is measured at the beginning of the study and before the start of the intervention in both groups, and 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 days after the intervention is measured in the intervention group. Method of measurement: Patient's report.;Complications associated with migraine such as eye and digestive complications. Timepoint: Complications are measured at the beginning of the study and before the start of the intervention in both groups and 7,14,21,28,35,42,49,56,63,70,77 and 84 days after the intervention in the intervention group. Method of measurement: Patient's report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Ghorbani

Sabzevar University of Medical Sciences

nahid68ghorbani@gmail.com+98 51 4263 3909

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026